VDR DE MEXICO DISTRIBUCION Q1-2026 supplier risk profile—80 suppliers, 225 shipments, India-concentrated sourcing.
VDR DE MEXICO DISTRIBUCION processed 225 shipments across 80 suppliers in 16 countries during Q1 2026. India dominated the sourcing footprint with 101 shipments (44.9% share), followed by Switzerland (30 shipments) and China (28 shipments). The importer's portfolio concentrated heavily on HS Chapter 39 (plastics), particularly HS code 392049 (30 shipments), alongside pharmaceutical and chemical intermediates. Top suppliers included Perlen Packaging from Switzerland (25 shipments) and India-based pharmaceutical manufacturers Orbit Lifescience and IPCA Laboratories.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
VDR DE MEXICO DISTRIBUCION registered zero sanctions watchlist matches and zero suppliers with forced-labor exposure flagging in Q1 2026. The importer's overall risk score is 75 (grade B), reflecting a moderate compliance posture with no immediate red-flag indicators in the provided screening data.
80 distinct tier-1 suppliers in Q1 2026
| PERLEN PACKAGING PERLEN | Switzerland | 25 |
| ORBIT LIFESCIENCE | India | 13 |
| RIKEN VITAMIN | United States | 12 |
| IPCA LABORATORIES | India | 12 |
| EMSLAND-STARKE | Germany | 9 |
| SRI KRISHNA PHARMACEUTICALS | India | 8 |
| DAEPYUNG | - | 8 |
| AARTI DRUGS | India | 7 |
Share of Q1 2026 inbound shipments by source country
106 tier-2 + 128 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.